Pirfenidone ameliorates pulmonary arterial pressure and neointimal remodeling in experimental pulmonary arterial hypertension by suppressing NLRP3 inflammasome activation
- DOI
- 10.1002/pul2.12101
- Published
- 2022-07
- Container
- Pulmonary Circulation
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1002/pul2.12101,
title = {Pirfenidone ameliorates pulmonary arterial pressure and neointimal remodeling in experimental pulmonary arterial hypertension by suppressing NLRP3 inflammasome activation},
author = {Emmanouil Mavrogiannis and Quint A. J. Hagdorn and Venetia Bazioti and Johannes M. Douwes and Diederik E. Van Der Feen and Silke U. Oberdorf‐Maass and Marit Westerterp and Rolf M. F. Berger},
year = {2022},
journal = {Pulmonary Circulation},
doi = {10.1002/pul2.12101},
url = {https://doi.org/10.1002/pul2.12101}
}RIS
TY - JOUR TI - Pirfenidone ameliorates pulmonary arterial pressure and neointimal remodeling in experimental pulmonary arterial hypertension by suppressing NLRP3 inflammasome activation AU - Emmanouil Mavrogiannis AU - Quint A. J. Hagdorn AU - Venetia Bazioti AU - Johannes M. Douwes AU - Diederik E. Van Der Feen AU - Silke U. Oberdorf‐Maass AU - Marit Westerterp AU - Rolf M. F. Berger PY - 2022 JO - Pulmonary Circulation DO - 10.1002/pul2.12101 UR - https://doi.org/10.1002/pul2.12101 ER -
APA
Mavrogiannis, E., Hagdorn, Q. A. J., Bazioti, V., Douwes, J. M., Feen, D. E. V. D., Oberdorf‐Maass, S. U., Westerterp, M., & Berger, R. M. F. (2022). Pirfenidone ameliorates pulmonary arterial pressure and neointimal remodeling in experimental pulmonary arterial hypertension by suppressing NLRP3 inflammasome activation. Pulmonary Circulation. https://doi.org/10.1002/pul2.12101
Source records
- crossref · retrieved 2026-11-10T09:08:53.338Z